A detailed history of British Columbia Investment Management Corp transactions in Amgen Inc stock. As of the latest transaction made, British Columbia Investment Management Corp holds 89,506 shares of AMGN stock, worth $23.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
89,506
Previous 102,649 12.8%
Holding current value
$23.7 Million
Previous $32.1 Million 10.08%
% of portfolio
0.18%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $4.07 Million - $4.43 Million
-13,143 Reduced 12.8%
89,506 $28.8 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $10.1 Million - $12.3 Million
38,537 Added 60.11%
102,649 $32.1 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $682,123 - $823,408
2,537 Added 4.12%
64,112 $18.2 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $3.32 Million - $3.75 Million
12,988 Added 26.73%
61,575 $17.7 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $69,749 - $86,595
319 Added 0.66%
48,587 $13.1 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $121,276 - $143,407
566 Added 1.19%
48,268 $10.7 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $60,511 - $73,753
268 Added 0.56%
47,702 $11.5 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $1.26 Million - $1.6 Million
-5,503 Reduced 10.4%
47,434 $12.5 Million
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $2.63 Million - $2.97 Million
-11,730 Reduced 18.14%
52,937 $11.9 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $5.17 Million - $5.75 Million
-22,392 Reduced 25.72%
64,667 $15.7 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $2.8 Million - $3.1 Million
-12,773 Reduced 12.79%
87,059 $21.1 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $1.28 Million - $1.46 Million
-6,417 Reduced 6.04%
99,832 $22.5 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $124,814 - $146,235
-588 Reduced 0.55%
106,249 $22.6 Million
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $2.61 Million - $2.9 Million
11,189 Added 11.7%
106,837 $26 Million
Q1 2021

Apr 30, 2021

SELL
$221.91 - $258.6 $760,707 - $886,480
-3,428 Reduced 3.46%
95,648 $23.8 Million
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $650,221 - $774,298
-3,005 Reduced 2.94%
99,076 $22.8 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $1.76 Million - $1.95 Million
7,491 Added 7.92%
102,081 $25.9 Million
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $5.84 Million - $7.17 Million
29,536 Added 45.4%
94,590 $22.3 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $13.9 Million - $18.5 Million
-76,459 Reduced 54.03%
65,054 $13.2 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $3.02 Million - $3.89 Million
-15,981 Reduced 10.15%
141,513 $34.1 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $7.26 Million - $8.7 Million
-41,713 Reduced 20.94%
157,494 $30.5 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $187,370 - $219,640
1,124 Added 0.57%
199,207 $36.7 Million
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $9.89 Million - $11.1 Million
-54,680 Reduced 21.63%
198,083 $37.6 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $2.43 Million - $2.84 Million
13,614 Added 5.69%
252,763 $49.2 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $16.6 Million - $18.7 Million
-89,537 Reduced 27.24%
239,149 $49.6 Million
Q2 2018

Aug 09, 2018

SELL
$166.05 - $186.51 $19.4 Million - $21.8 Million
-116,664 Reduced 26.2%
328,686 $60.7 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $10.1 Million - $11.8 Million
-59,583 Reduced 11.8%
445,350 $75.9 Million
Q4 2017

Feb 20, 2018

BUY
$168.79 - $188.59 $4.26 Million - $4.76 Million
25,237 Added 5.26%
504,933 $87.8 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $80.2 Million - $91.6 Million
479,696
479,696 $89.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.